Elisabeth Mahase The BMJ

Relying on the discovery of new antibiotics as the main solution to antimicrobial resistance (AMR) is not realistic and scientists should instead be looking to alternatives such as vaccines and faecal transplantations, according to a researcher from the National Institute for Biological Standards and Control.

Gregory Amos, who heads up the microbiome section of the standards body—part of the Medicines and Healthcare Products Regulatory Agency—said that multiple strategies are needed to overcome AMR and, while “new antibiotics would be nice, what we really need to do is reduce our dependency and usage of antibiotics.”

He suggested this could be …